Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization
Arghavan Zebardast, Parastoo Hosseini, Ali Hasanzadeh, et al.
Molecular Biology Reports (2021) Vol. 49, Iss. 1, pp. 647-656
Open Access | Times Cited: 13

Showing 13 citing articles:

Nanobodies: Robust miniprotein binders in biomedicine
Jeffrey Yong Joon Kim, Zhe Sang, Yufei Xiang, et al.
Advanced Drug Delivery Reviews (2023) Vol. 195, pp. 114726-114726
Open Access | Times Cited: 44
The Potential of Nanobodies for COVID-19 Diagnostics and Therapeutics
Dhaneshree Bestinee Naidoo, Anil A. Chuturgoon
Molecular Diagnosis & Therapy (2023) Vol. 27, Iss. 2, pp. 193-226
Open Access | Times Cited: 20
Aptamers and Nanobodies as New Bioprobes for SARS-CoV-2 Diagnostic and Therapeutic System Applications
Ki Sung Park, Tae-In Park, Jae Eon Lee, et al.
Biosensors (2024) Vol. 14, Iss. 3, pp. 146-146
Open Access | Times Cited: 6
Nanobodies: from structure to applications in non-injectable and bispecific biotherapeutic development
Bingxuan Li, Xiaohong Qin, Li-Zhi Mi
Nanoscale (2022) Vol. 14, Iss. 19, pp. 7110-7122
Closed Access | Times Cited: 21
A Class of Shark‐Derived Single‐Domain Antibodies can Broadly Neutralize SARS‐Related Coronaviruses and the Structural Basis of Neutralization and Omicron Escape
Bo Feng, Zhilong Chen, Jing Sun, et al.
Small Methods (2022) Vol. 6, Iss. 7
Open Access | Times Cited: 19
Therapeutic applications of nanobodies against SARS-CoV-2 and other viral infections: Current update
Manojit Bhattacharya, Srijan Chatterjee, Sang‐Soo Lee, et al.
International Journal of Biological Macromolecules (2022) Vol. 229, pp. 70-80
Open Access | Times Cited: 19
Identification of nurse shark VNAR single‐domain antibodies targeting the spike S2 subunit of SARS‐CoV‐2
Jesse Buffington, Zhijian Duan, Hyung Joon Kwon, et al.
The FASEB Journal (2023) Vol. 37, Iss. 6
Open Access | Times Cited: 9
Next generation single-domain antibodies against respiratory zoonotic RNA viruses
Iris C. Swart, W. van Gelder, Cornelis A. M. de Haan, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2
Monobodies with potent neutralizing activity against SARS-CoV-2 Delta and other variants of concern
T. Kondo, Kazuhiro Matsuoka, Shun Umemoto, et al.
Life Science Alliance (2022) Vol. 5, Iss. 6, pp. e202101322-e202101322
Open Access | Times Cited: 6
Structure basis of two nanobodies neutralizing SARS-CoV-2 Omicron variant by targeting ultra-conservative epitopes
Zengchao Sun, Lu Wang, Lingyun Li, et al.
Journal of Structural Biology (2023) Vol. 215, Iss. 3, pp. 107996-107996
Closed Access | Times Cited: 3
Voltammetric Sensors: A Versatile Tool in COVID‐19 Diagnosis and Prognosis
Souparnika Nambiar, Malavika Mohan, Ammu Rosin Jose
ChemistrySelect (2023) Vol. 8, Iss. 6
Closed Access | Times Cited: 2
Resistance-based directed evolution of nanobodies for higher affinity in prokaryotes
Yue Hu, Li Huo, Weiwei Chen, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 11, pp. 130710-130710
Closed Access
The Search for Single-Domain Antibodies Interacting with the Receptor-Binding Domain of SARS-CoV-2 Surface Protein
V. S. Aripov, Н. В. Волкова, Alexander V. Taranin, et al.
Bulletin of Experimental Biology and Medicine (2023) Vol. 175, Iss. 2, pp. 225-228
Closed Access
Page 1

Scroll to top